Cardiac regenerative medicine represents a promising strategy aimed at restoring impaired heart function by replacing or ...

The requirements for receiving an RMAT designation include that the drug candidate is an advanced regenerative medicine, in this case a gene therapy; that the therapy is targeting a serious condition, ...

Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.

Despite political headwinds through administrations from Bush to Trump, the Yale Stem Cell Center has emerged as a global leader in regenerative medicine. “As we live longer, a lot of previously ‘not ...

These lab-made tissues are being developed for applications such as drug testing, disease modeling and regenerative medicine, with the long-term goal of creating functional replacements for damaged or ...